|
CSRNP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.850440E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.862200E-03 |
| Normal-vs-Stage2 |
1.723200E-01 |
| Normal-vs-Stage3 |
2.548000E-01 |
| Normal-vs-Stage4 |
5.462300E-02 |
| Stage1-vs-Stage2 |
3.086600E-01 |
| Stage1-vs-Stage3 |
6.175900E-02 |
| Stage1-vs-Stage4 |
5.565000E-01 |
| Stage2-vs-Stage3 |
7.341800E-01 |
| Stage2-vs-Stage4 |
6.949600E-01 |
| Stage3-vs-Stage4 |
4.298400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.377820E-02 |
| Normal-vs-AfricanAmerican |
2.264500E-02 |
| Normal-vs-Asian |
2.876200E-02 |
| Caucasian-vs-AfricanAmerican |
4.332000E-01 |
| Caucasian-vs-Asian |
7.920200E-01 |
| AfricanAmerican-vs-Asian |
6.188000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.866500E-02 |
| Normal-vs-Female |
1.598030E-02 |
| Male-vs-Female |
5.296400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.297870E-03 |
| Normal-vs-Age(41-60Yrs) |
1.452980E-01 |
| Normal-vs-Age(61-80Yrs) |
3.787800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.774800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.348490E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.644100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.103600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.557800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.853200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.786400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.782800E-01 |
| Classical-VS-Follicular |
4.366600E-04 |
| Classical-VS-Other |
9.887000E-01 |
| Classical-VS-Normal |
7.045400E-04 |
| Tall-VS-Follicular |
1.380020E-01 |
| Tall-VS-Other |
5.699600E-01 |
| Tall-VS-Normal |
1.265570E-01 |
| Follicular-VS-Other |
2.611400E-01 |
| Follicular-VS-Normal |
9.170000E-01 |
| Other-VS-Normal |
1.566360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.301600E-01 |
| Normal-vs-N1 |
3.819000E-03 |
| N0-vs-N1 |
1.684080E-02 |
|
|
